azelaprag tirzepatide BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity and Metabolic Disease Therapeutics Useful research chemical for a range of applications SEC Filing | BioAge Labs,

US$ 28.64

★★★★★ 5.0 (25 reviews)

US$ 27.84

★★★★★ 4.3 (8 reviews)

US$ 21.01

★★★★★ 4.5 (13 reviews)

US$ 29.71

★★★★★ 4.8 (15 reviews)

US$ 23.89

★★★★★ 4.0 (22 reviews)

US$ 28.77

★★★★★ 4.9 (18 reviews)

US$ 24.49

★★★★★ 4.9 (11 reviews)

US$ 22.03

★★★★★ 4.2 (30 reviews)

US$ 26.81

★★★★★ 4.9 (29 reviews)

US$ 25.63

★★★★★ 4.7 (8 reviews)

US$ 25.84

★★★★★ 4.9 (19 reviews)

US$ 27.78

★★★★★ 4.0 (9 reviews)

US$ 22.50

★★★★★ 4.1 (27 reviews)

US$ 23.32

★★★★★ 4.1 (21 reviews)

US$ 29.17

★★★★★ 4.3 (22 reviews)

US$ 23.57

★★★★★ 4.4 (17 reviews)

US$ 21.82

★★★★★ 4.4 (6 reviews)

US$ 24.90

★★★★★ 4.6 (22 reviews)

US$ 24.99

★★★★★ 4.7 (14 reviews)

US$ 20.23

★★★★★ 4.6 (11 reviews)